BET domain co-regulators in obesity, inflammation and cancer

Nature Reviews Cancer

Volumn 12, Issue 7, 2012, Pages 465-477

  Belkina, Anna C ^a   Denis, Gerald V ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMODOMAIN AND EXTRATERMINAL PROTEIN; CHROMOSOME PROTEIN; HISTONE ACETYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ALPHA HELIX; ARABIDOPSIS; CAENORHABDITIS ELEGANS; CELL CYCLE REGULATION; CHROMATIN; CHROMOSOME TRANSLOCATION; COMPLEX FORMATION; DNA BINDING MOTIF; DROSOPHILA MELANOGASTER; EPIGENETICS; GENE EXPRESSION; GENE TARGETING; HISTONE MODIFICATION; HUMAN; INFLAMMATION; NEOPLASM; NONHUMAN; NUCLEOSOME; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SACCHAROMYCES CEREVISIAE; VIRUS LATENCY; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ZEBRA FISH;

CHROMATIN; EPIGENESIS, GENETIC; HUMANS; INFLAMMATION; NEOPLASMS; NUCLEAR PROTEINS; OBESITY; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS;

EID: 84862738480     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3256     Document Type: Review

References (182)

1. Kubonishi, I. et al. Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res. 51, 3327-3328 (1991).
2. French, C. A. et al. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 63, 304-307 (2003). (Pubitemid 36152484)
3. French, C. A. et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 27, 2237-2242 (2008). (Pubitemid 351483375)
4. Florence, B. & Faller, D. V. You bet-cha: a novel family of transcriptional regulators. Front. Biosci. 6, D1008-D1018 (2001).
5. Wu, S. Y. & Chiang, C. M. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem. 282, 13141-13145 (2007).
6. Haynes, S. R. et al. The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins. Nucl. Acids Res. 20, 2603 (1992).
7. Jeanmougin, F., Wurtz, J.-M., Le Douarin, B., Chambon, P. & Losson, R. The bromodomain revisited. Trends Biochem. Sci. 22, 151-153 (1997).
8. Winston, F. & Allis, C. D. The bromodomain: a chromatin-targeting module? Nature Struct. Biol. 6, 601-604 (1999). (Pubitemid 29318942)
9. Horn, P. J. & Peterson, C. L. The bromodomain: a regulator of ATP-dependent chromatin remodeling? Front. Biosci. 6, D1019-1023 (2001).
10. Jiang, Y. W. et al. Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways. Proc. Natl Acad. Sci. USA 95, 8538-8543 (1998). (Pubitemid 28350523)
11. Kuras, L., Borggrefe, T. & Kornberg, R. D. Association of the Mediator complex with enhancers of active genes. Proc. Natl Acad. Sci. USA 100, 13887-13891 (2003). (Pubitemid 37499161)
12. Kornberg, R. D. Mediator and the mechanism of transcriptional activation. Trends Biochem. Sci. 30, 235-239 (2005). (Pubitemid 40693865)
13. Dhalluin, C. et al. Structure and ligand of a histone acetyltransferase bromodomain. Nature 399, 491-496 (1999). (Pubitemid 29258857)
14. Sanchez, R. & Zhou, M.-M. The role of human bromodomains in chromatin biology and gene transcription. Curr. Opin. Drug Discov. Dev. 12, 659-665 (2009).
15. Tamkun, J. W. et al. brahma-a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SWI2/SNF2. Cell 68, 561-572 (1992).
16. Wang, W. et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 15, 5370-5382 (1996). (Pubitemid 26336219)
17. Pazin, M. J. & Kadonaga, J. T. SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions? Cell 88, 737-740 (1997). (Pubitemid 27164261)
18. Ogryzko, V. V., Schiltz, O. L., Russanova, V., Howard, B. H. & Nakatani, Y. The transcriptional co-activators p300 and CBP are histone acetyltransferases. Cell 87, 953-959 (1996). (Pubitemid 26404293)
19. Bannister, A. J. & Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643 (1996). (Pubitemid 27021517)
20. Beck, S., Hanson, I., Kelly, A., Pappin, D. J. C. & Trowsdale, J. A homologue of the Drosophila female sterile homeotic (fsh) gene in the class II region of the human MHC. DNA Seq. 2, 203-210 (1992).
21. Matangkasombut, O., Buratowski, R. M., Swilling, N. W. & Buratowski, S. Bromodomain factor 1 corresponds to the missing piece of yeast TFIID. Genes Dev. 14, 951-962 (2000). (Pubitemid 30253004)
22. Thorpe, K. L., Abdulla, S., Kaufman, J., Trowsdale, J. & Beck, S. Phylogeny and structure of the RING3 gene. Immunogenet. 44, 391-396 (1996).
23. Salter-Cid, L., Pasquier, L. & Flajnik, M. RING3 is linked to the Xenopus major histocompatibility complex. Immunogenet. 44, 397-399 (1996). (Pubitemid 26293855)
24. Takami, K., Zaleska-Rutczynska, Z., Figueroa, F. & Klein, J. Linkage of LMP, TAP, and RING3 with Mhc class I rather than class II genes in the zebrafish. J. Immunol. 159, 6052-6060 (1997). (Pubitemid 127471542)
25. Deshaies, R. J. & Joazeiro, C. A. P. RING domain E3 ubiquitin ligases. Ann. Rev. Biochem. 78, 399-434 (2009).
26. Ting, J. P. & Trowsdale, J. Genetic control of MHC class II expression. Cell 109, S21-33 (2002). (Pubitemid 34457849)
27. Denis, G. V. & Green, M. R. A novel, mitogen-activated nuclear kinase is related to a Drosophila developmental regulator. Genes Dev. 10, 261-271 (1996). (Pubitemid 26058959)
28. Guo, N., Faller, D. V. & Denis, G. V. Activation-induced nuclear translocation of RING3. J. Cell Sci. 113, 3085-3091 (2000).
29. Denis, G. V., Vaziri, C., Guo, N. & Faller, D. V. RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F. Cell Growth Diff. 11, 417-424 (2000). (Pubitemid 30644365)
30. Ostrowski, J., Florio, S. K., Denis, G. V., Suzuki, H. & Bomsztyk, K. Stimulation of p85/RING3 kinase in multiple organs after systemic administration of mitogens into mice. Oncogene 16, 1223-1227 (1998). (Pubitemid 28127522)
31. Crowley, T. E., Kaine, E. M., Yoshida, M., Nandi, A. & Wolgemuth, D. J. Reproductive cycle regulation of nuclear import, euchromatic localization, and association with components of Pol. II mediator of a mammalian double-bromodomain protein. Mol. Endocrinol. 16, 1727-1737 (2002). (Pubitemid 34828084)
32. Kanno, T. et al. Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol. Cell. 13, 33-43 (2004). (Pubitemid 38117113)
33. Nakamura, Y. et al. Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4. J. Biol. Chem. 282, 4193-4201 (2007). (Pubitemid 47084445)
34. Denis, G. V. et al. Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines. J. Proteome Res. 5, 502-511 (2006). (Pubitemid 43364089)
35. LeRoy, G., Rickards, B. & Flint, S. J. The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol. Cell. 30, 51-60 (2008). (Pubitemid 351470152)
36. Denis, G. V. Bromodomain motifs and "scaffolding"? Front. Biosci. 6, D1066-D1068 (2001).
37. Peng, J. et al. Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation. Mol. Cell. Biochem. 294, 45-54 (2007). (Pubitemid 46188885)
38. Sinha, A., Faller, D. V. & Denis, G. V. Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A. Biochem. J. 387, 257-269 (2005). (Pubitemid 40524096)
39. Lin, Y. J. et al. Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4. Protein Sci.17, 2174-2179 (2008).
40. Rahman, S. et al. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol. Cell. Biol. 31, 2641-2652 (2011).
41. Bartkova, J. et al. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57, 353-361 (1994). (Pubitemid 24168609)
42. Courjal, F. et al. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: Definition of phenotypic groups. Cancer Res. 57, 4360c4367 (1997).
43. Ormandy, C. J. et al. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res. Treat. 78, 323-335 (2003). (Pubitemid 36543212)
44. Jang, M. K. et al. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell. 19, 523-534 (2005).
45. Yang, Z. et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol. Cell. 19, 535-545 (2005). (Pubitemid 41140010)
46. Marshall, N. F., Peng, J., Xie, Z. & Price, D. H. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271, 27176-27183 (1996). (Pubitemid 26359140)
47. Yang, Z., He, N. & Zhou, Q. Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression. Mol. Cell. Biol. 28, 967-976 (2008). (Pubitemid 351160053)
48. Maruyama, T. et al. A Mammalian bromodomain protein, Brd4, interacts with replication factor C and inhibits progression to S phase. Mol. Cell. Biol. 22, 6509-6520 (2002).
49. Dey, A., Chitsaz, F., Abbasi, A., Misteli, T. & Ozato, K. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc. Natl Acad. Sci. USA. 100, 8758-8763 (2003). (Pubitemid 36899172)
50. Zhang, L. et al. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis 31, 559-566 (2010).
51. Dey, A. et al. A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition. Mol. Cell. Biol. 20, 6537-6549 (2000). (Pubitemid 30650239)
52. Umehara, T. et al. Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain. J. Biol. Chem. 285, 7610-7618 (2010).
53. Nishiyama, A., Dey, A., Miyazaki, J. & Ozato, K. Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: preservation of acetylated chromatin. Mol. Biol. Cell. 17, 814-823 (2006). (Pubitemid 43191115)
54. Laue, K. et al. The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity. Development 135, 1935-1946 (2008). (Pubitemid 351943358)
55. Toyama, R., Rebbert, M. L., Dey, A. & Ozato, K. & Dawid, I. B. Brd4 associates with mitotic chromosomes throughout early zebrafish embryogenesis. Dev. Dyn. 237, 1636-1644 (2008). (Pubitemid 351813060)
56. Dey, A., Nishiyama, A., Karpova, T., McNally, J. & Ozato, K. Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol. Biol. Cell 20, 4899-4909 (2009).
57. Chua, P. & Roeder, G. S. Bdf1, a yeast chromosomal protein required for sporulation. Mol. Cell. Biol. 15, 3685-3696 (1995).
58. Della Rovere, F. et al. The Arabidopsis BET bromodomain factor GTE4 regulates the mitotic cell cycle. Plant Signal Behav. 5, 677-680 (2010).
59. Airoldi, C. A. et al. The Arabidopsis BET bromodomain factor GTE4 is involved in maintenance of the mitotic cell cycle during plant development. Plant Physiol. 152, 1320-1334 (2010).
60. Shibata, Y., Takeshita, H., Sasakawa, N. & Sawa, H. Double bromodomain protein BET-1 and MYST HATs establish and maintain stable cell fates in C. elegans. Development 137, 1045-1053 (2010).
61. You, J. et al. Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J. Virol. 80, 8909-8919 (2006). (Pubitemid 44359965)
62. Zhao, R., Nakamura, T., Fu, Y., Lazar, Z. & Spector, D. L. Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation. Nature Cell Biol. 13, 1295-1304 (2011).
63. Gyuris, A. et al. The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis. Biochim. Biophys. Acta. 1789, 413-421 (2009).
64. Shang, E., Wang, X., Wen, D., Greenberg, D. A. & Wolgemuth, D. J. Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse. Dev. Dyn. 238, 908-917 (2009).
65. Wang, F. et al. Brd2 disruption in mice causes severe obesity without type 2 diabetes. Biochem. J. 425, 71-83 (2009).
66. Houzelstein, D. et al. Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4. Mol. Cell. Biol. 22, 3794-3802 (2002). (Pubitemid 34525221)
67. You, J. et al. Regulation of aurora B expression by the bromodomain protein Brd4. Mol. Cell. Biol. 29, 5094-5103 (2009).
68. Lygerou, Z. et al. The yeast BDF1 gene encodes a transcription factor involved in the expression of a broad class of genes including snRNAs. Nucl. Acids Res. 22, 5332-5340 (1994).
69. Matangkasombut, O. & Buratowski, S. Different sensitivities of bromodomain factors 1 and 2 to histone H4 acetylation. Mol. Cell 11, 353-363 (2003). (Pubitemid 36293830)
70. Jacobson, R. H., Ladurner, A. G., King, D. S. & Tjian, R. Structure and function of a human TAFII250 double bromodomain module. Science 288, 1422-1425 (2000). (Pubitemid 30366328)
71. Dunphy, E. L., Johnson, T., Auerbach, S. S. & Wang, E. H. Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression. Mol. Cell. Biol. 20, 1134-1139 (2000). (Pubitemid 30069233)
72. Wang, E. H., Zou, S. & Tjian, R. TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins. Genes Dev. 11, 2658-2669 (1997). (Pubitemid 27452389)
73. Iacobuzio-Donahue, C. A. Epigenetic changes in cancer. Ann. Rev. Pathol. 4, 229-249 (2009).
74. Redner, R. L., Wang, J. & Liu, J. M. Chromatin remodeling and leukaemia: new therapeutic paradigms. Blood 94, 417-428 (1999). (Pubitemid 29323855)
75. Borrow, J. et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nature Genet. 14, 33-41 (1996).
76. Sobulo, O. M. et al. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukaemia with a t(11;16)(q23;p13.3). Proc. Natl Acad. Sci. USA 94, 8732-8737 (1997). (Pubitemid 27335108)
77. Lavau, C., Du, C., Thirman, M. & Zeleznik-Le, N. Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukaemia. EMBO J. 19, 4655-4664 (2000).
78. Martens, J. H. et al. PML-RARalpha/RXR alters the epigenetic landscape in Acute Promyelocytic Leukaemia. Cancer Cell 17, 173-185 (2010).
79. Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067-1073 (2010).
80. Muller, S., Filippakopoulos, P. & Knapp, S. Bromodomains as therapeutic targets. Expert Rev. Mol. Med. 13, e29 (2011).
81. Mertz, J. A. et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc. Natl Acad. Sci. USA 108, 16669-16674 (2011).
82. Seoane, J., Le, H. V. & Massagué, J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419, 729-734 (2002). (Pubitemid 35177959)
83. Boxer, L. M. & Dang, C. V. Translocations involving c-myc and c-myc function. Oncogene 20, 5595-5610 (2001). (Pubitemid 32928100)
84. Zuber, J. et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524-528 (2011).
85. Ciro, M. et al. ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Cancer Res. 69, 8491-8498 (2009).
86. Caron, C. et al. Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers. Oncogene 29, 5171-5181 (2010).
87. Soucek, L. et al. Modelling Myc inhibition as a cancer therapy. Nature 455, 679-683 (2008).
88. Soucek, L., Nasi, S. & Evan, G. I. Omomyc expression in skin prevents Myc-induced papillomatosis. Cell Death Differ. 11, 1038-1045 (2004). (Pubitemid 39232363)
89. Centeno, F. Ramírez-Salazar, E., García-Villa, E., Gariglio, P. & Garrido, E. TAF1 interacts with and modulates human papillomavirus 16 E2-dependent transcriptional regulation. Intervirology 51, 137-143 (2008).
90. Zhou, M. et al. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29. J. Virol. 83, 1036-1044 (2009).
91. Mueller, D. et al. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood 110, 4445-4454 (2007). (Pubitemid 351377811)
92. Dawson, M. A. et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478, 529-533 (2011).
93. Greenwald, R. J. et al. Eμ-BRD2 transgenic mice develop B cell lymphoma and leukaemia. Blood 103, 1475-1484 (2004). (Pubitemid 38168665)
94. Lenburg, M. E., Sinha, A., Faller, D. V. & Denis, G. V. Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis. J. Biol. Chem. 282, 4803-4811 (2007). (Pubitemid 47100938)
95. French, C. A. Pathogenesis of NUT midline carcinoma. Ann. Rev. Pathol. Mech. Dis. 7, 247-265 (2012).
96. Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904-917 (2011).
97. Nicodeme, E. et al. Suppression of inflammation by a synthetic histone mimic. Nature 468, 1119-1123 (2010).
98. Ouchida, R. et al. Suppression of NF-κB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells. Genes Cells 8, 95-107 (2003). (Pubitemid 36519090)
99. Hewings, D. S. et al. 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands. J. Med. Chem. 54, 6761-6770 (2011).
100. Chung, C. W., Dean, A. W., Woolven, J. M. & Bamborough, P. Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery. J. Med. Chem. 55, 576-586 (2012).
101. Bamborough, P. et al. Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides. J. Med. Chem. 55, 587-596 (2012).
102. Belkina, A. C., Blanton, W., Wang, F., Liu, H. & Denis, G. V. Whole body Brd2 deficiency protects obese mice from insulin resistance by creating a low inflammatory environment. Obesity 18, S58 (2010).
103. Denis, G. V. Bromodomain coactivators in cancer, obesity, type 2 diabetes and inflammation. Discov. Med. 10, 489-499 (2010).
104. Andres, R. Effect of obesity on total mortality. Int. J. Obes. 4, 381-386 (1980). (Pubitemid 10006809)
105. Sims, E. A. H. Are there persons who are obese, but metabolically healthy? Metabolism 50, 1499-1504 (2001). (Pubitemid 34007425)
106. Klφting, N. et al. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 299, E506-E515 (2010).
107. Bonora, E., et al. U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population. The Bruneck Study. Diabetes Care 21, 221-230 (1991).
108. Wildman, R. P. et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population Arch. Intern. Med. 168, 1617-1624 (2008).
109. Karelis, A. D. et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J. Clin. Endocrinol. Metab. 90, 4145-4150 (2005). (Pubitemid 41058189)
110. Succurro, E. et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity (Silver Spring) 16, 1881-1886 (2008).
111. Calori, G. et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34, 210-215 (2011).
112. Huang, B., Yang, X. D., Zhou, M. M., Ozato, K. & Chen, L. F. Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol. Cell. Biol. 29, 1375-1387 (2009).
113. Cullen, S. J., Ponnappan, S. & Ponnappan, U. Catalytic activity of the proteasome finetunes Brg1-mediated chromatin remodeling to regulate the expression of inflammatory genes. Mol. Immunol. 47, 600-605 (2009).
114. Karin, M. NF-κB as a critical link between inflammation and cancer. Cold Spring Harb. Perspect. Biol. 1, a000141 (2009).
115. Virchow, R. Cellular Pathology, as Based on Physiological and Pathological Histology. (ed. Chance, F.) (J. Churchill, 1860).
116. Goldgraber, M. B., Humphreys, E. M., Kirsner, J. B. & Palmer, W. L. Carcinoma and ulcerative colitis, a clinical-pathologic study. II. Statistical analysis. Gastroenterology 34, 840-846 (1958).
117. Kraus, S. & Arber, N. Inflammation and colorectal cancer. Curr. Opin. Pharmacol. 9, 405-410 (2009).
118. Denis, G. V., Nikolajczyk, B. N. & Schnitzler, G. R. An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis. FEBS Lett. 584, 3260-3268 (2010).
119. Chung, C. W. et al. Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J. Med. Chem. 54, 3827-3838 (2011).
120. Pamblanco, M. et al. Bromodomain factor 1 (Bdf1) protein interacts with histones. FEBS Lett. 496, 31-35 (2001). (Pubitemid 32451763)
121. Chang, Y. L., King, B., Lin, S. C., Kennison, J. A. & Huang, D. H. A double-bromodomain protein, FSH-S, activates the homeotic gene ultrabithorax through a critical promoter-proximal region. Mol. Cell. Biol. 27, 5486-5498 (2007). (Pubitemid 47124401)
122. Florence, B. L. & Faller, D. V. Drosophila female sterile (1) homeotic is a multifunctional transcriptional regulator that is modulated by Ras signaling. Dev. Dyn. 237, 554-564 (2008). (Pubitemid 351398023)
123. Denis, G. V. Duality in bromodomain-containing protein complexes. Front. Biosci. 6, D849-D852 (2001).
124. Trouche, D., Le Chalony, C., Muchardt, C., Yaniv, M. & Kouzarides, T. RB and hbrm cooperate to repress the activation functions of E2F1. Proc. Natl Acad. Sci. USA 94, 11268-11273 (1997). (Pubitemid 27450987)
125. Zhang, H. S. et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101, 79-89 (2000).
126. Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597-601 (1998). (Pubitemid 28157603)
127. Ferreira, R., Magnaghi-Jaulin, L., Robin, P., Harel-Bellan, A. & Trouche, D. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc. Natl Acad. Sci. USA 95, 10493-10498 (1998). (Pubitemid 28413095)
128. Magnaghi-Jaulin, L. et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601-605 (1998). (Pubitemid 28157604)
129. Stiegler, P., De Luca, A., Bagella, L. & Giordano, A. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. Cancer Res. 58, 5049-5052 (1998). (Pubitemid 28521158)
130. Blobel, G. A., Kalota, A., Sanchez, P. V. & Carroll, M. Short hairpin RNA screen reveals bromodomain proteins as novel targets in acute myeloid leukaemia. Cancer Cell 20, 287-288 (2011).
131. Sachs, L. Control of normal cell differentiation in leukemic cells. Haematologica 61, 93-97 (1976).
132. Sachs, L. Leukemogenesis and differentiation. Ann. Rev. Med. 36, 177-184 (1985).
133. Dibenedetto, A. J. et al. Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergence. BMC Dev. Biol. 8, 39 (2008).
134. Sun, H. et al. Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4. Biochem. Biophys. Res. Commun. 358, 435-441 (2007). (Pubitemid 46755725)
135. Tae, S. et al. Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes. Nucleic Acids Res. 39, 5424-5438 (2011).
136. Ladurner, A. G., Inouye, C., Jain, R. & Tjian, R. Bromodomains mediate an acetyl-histone encoded antisilencing function at heterochromatin boundaries. Mol. Cell. 11, 365-376 (2003). (Pubitemid 36293831)
137. Hang, M. & Smith, M. M. Genetic analysis implicates the Set3/Hos2 histone deacetylase in the deposition and remodeling of nucleosomes containing H2AZ. Genetics 187, 1053-1066 (2011).
138. Look, A. T. Oncogenic transcription factors in the human acute leukaemias. Science 278, 1059-1064 (1997). (Pubitemid 27517875)
139. Rowley, J. D. The critical role of chromosome translocations in human leukaemias. Ann. Rev. Genet. 32, 495-519 (1998). (Pubitemid 29045322)
140. Wilson, B. G. & Roberts, C. W. M. SWI/SNF nucleosome remodelers and cancer. Nature Rev. Cancer 11, 481-492 (2011).
141. Cowell, I. G., Papageorgiou, N., Padget, K., Watters, G. P. & Austin, C. A. Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin. Nucleus 2, 61-71 (2011).
142. Gkikopoulos, T. et al. The SWI/SNF complex acts to constrain distribution of the centromeric histone variant Cse4. EMBO J. 30, 1919-1927 (2011).
143. Lamonica, J. M. et al. Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes. Proc. Natl Acad. Sci. USA 108, E159-E168 (2011).
144. Gamsjaeger, R. et al. Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3. Mol. Cell. Biol. 31, 2632-2640 (2011).
145. Haslam, D. W. & James, W. P. Obesity. Lancet 366, 1197-1209 (2009). (Pubitemid 41393598)
146. Hossain, P., Kawar, B. & El Nahas, M. Obesity and diabetes in the developing world-a growing challenge. N. Engl. J. Med. 356, 213-215 (2007). (Pubitemid 46143224)
147. Devaiah, B. N. et al. BRD4 is an atypical kinase that phosphorylates serine 2 of the RNA Polymerase II carboxy-terminal domain. Proc. Natl Acad. Sci. USA 109, 6927-6932 (2012).
148. Gans, M., Audit, C. & Masson, M. Isolation and characterization of sex-linked female-sterile mutants in Drosophila melanogaster. Genetics 81, 683-704 (1975).
149. Gans, M., Forquignon, F. & Masson, M. The role of dosage of the region 7D1-7D5-6 of the X chromosome in the production of homeotic transformations in Drosophila melanogaster. Genetics 96, 887-902 (1980).
150. Digan, M. E. et al. Genetic and molecular analysis of fs(1)h, a maternal effect homeotic gene in Drosophila. Dev. Biol. 114, 161-169 (1986). (Pubitemid 16078395)
151. Mozer, B. A. & Dawid, I. B. Cloning and molecular characterization of the trithorax locus of Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 86, 3738-3742 (1989).
152. Mazo, A. M., Huang, D. H., Mozer, B. A. & Dawid, I. B. The trithorax gene, a trans-acting regulator of the bithorax complex in Drosophila, encodes a protein with zinc-binding domains. Proc. Natl Acad. Sci. USA 87, 2112-2116 (1990).
153. Cimino, G. et al. Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11) (p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res. 51, 6712-6714 (1991).
154. Djabali, M. et al. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nature Genet. 2, 113-118 (1992).
155. Gu, Y. et al. The t(4;11) chromosome translocation of human acute leukaemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71, 701-708 (1992).
156. Tkachuk, D. C., Kohler, S. & Cleary, M. L. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukaemias. Cell 71, 691-700 (1992).
157. McPhillips, M. G., Ozato, K. & McBride, A. A. Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J. Virol. 79, 8920-8932 (2005). (Pubitemid 40934803)
158. Hebner, C. M. & Laimins, L. A. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16, 83-97 (2006).
159. You, J., Croyle, J. L., Nishimura, A., Ozato, K. & Howley, P. M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117, 349-360 (2004). (Pubitemid 38534541)
160. Schweiger, M. R., You, J. & Howley, P. M. Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J. Virol. 80, 4276-4285 (2006).
161. McPhillips, M. G., Oliveira, J. G., Spindler, J. E., Mitra, R. & McBride, A. A. Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 80, 9530-9543 (2006). (Pubitemid 44435629)
162. Senechal, H., Poirier, G. G., Coulombe, B., Laimins, L. A. & Archambault, J. Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology 358, 10-17 (2007). (Pubitemid 46048882)
163. Wu, S. Y. et al. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 20, 2383-2396 (2006).
164. Smith, J. A. et al.Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc. Natl Acad. Sci. USA 107, 3752-3757 (2010).
165. Ilves, I., Maemets, K., Silla, T., Janikson, K. & Ustav, M. Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J. Virol. 80, 3660-3665 (2006).
166. Platt, G. M., Simpson, G. R., Mittnacht, S. & Schulz, T. F. Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J. Virol. 73, 9789-9795 (1999).
167. Viejo-Borbolla, A. et al. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J. Virol. 79, 13618-13629 (2005). (Pubitemid 41508174)
168. Ottinger, M. et al. Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4-and BRD2/RING3-induced G1 cell cycle arrest. J. Virol. 80, 10772-10786 (2006). (Pubitemid 44628923)
169. Radkov, S. A., Kellam, P. & Boshoff, C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nature Med. 6, 1121-1127 (2000).
170. Friborg, J. Jr, Kong, W., Hottiger, M. O. & Nabel, G. J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889-894 (1999).
171. Palermo, R. D., Webb, H. M. & West, M. J. R. N. A. Polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr Virus. PLoS Pathog. 7, e1002334 (2011).
172. Nagl, N. G. Jr, Zweitzig, D. R., Thimmapaya, B., Beck, G. R. Jr & Moran, E. The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation associated cell cycle arrest. Cancer Res. 66, 1289-1293 (2006). (Pubitemid 43259906)
173. Nagl, N. G. Jr, Wang, X., Patsialou, A., Van Scoy, M. & Moran, E. Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J. 26, 752-763 (2007).
174. Peterson, C. L. Chromatin remodeling: nucleosomes bulging at the seams. Curr. Biol. 12, R245-R247 (2002). (Pubitemid 34271357)
175. Sif, S., Saurin, A. J., Imbalzano, A. N. & Kingston, R. E. Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. Genes Dev. 15, 603-618 (2001). (Pubitemid 32205148)
176. Olave, I., Wang, W., Xue, Y., Kuo, A. & Crabtree, G. R. Identification of a polymorphic, neuron-specific chromatin remodeling complex. Genes Dev. 16, 2509-2517 (2002).
177. Bultman, S. et al. A Brg1 null mutation in the mouse reveals functional
178. Reyes, J. C. et al. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J. 17, 6979-6991 (1998). (Pubitemid 28550292)
179. Burns, L. G. & Peterson, C. L. The yeast SWI-SNF complex facilitates binding of a transcriptional activator to nucleosomal sites in vivo. Mol. Cell. Biol. 17, 4811-4819 (1997). (Pubitemid 27318156)
180. Holstege, F. C. et al. Dissecting the regulatory circuitry of a eukaryotic genome. Cell 95, 717-728 (1998). (Pubitemid 28544132)
181. Chua, Y. L., Channeliere, S., Mott, E. & Gray, J. C. The bromodomain protein GTE6 controls leaf development in Arabidopsis by histone acetylation at ASYMMETRIC LEAVES1. Genes Dev. 19, 2245-2254 (2005). (Pubitemid 41330325)
182. Wang, R., Li, Q., Helfer, C. M., Jiao, J. & You, J. Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure. J. Biol. Chem. 287, 10738-10752 (2012).